INOVIO PHARMACEUTICALS, INC. (INO) Insider Trading Disclosures
INOVIO PHARMACEUTICALS, INC. (INO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INO
CIK: 1055726
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerEmma Epes
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-06 | 2026-10-06 | 8-K | 0001193125-26-415555 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001055726-26-000024 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001055726-26-000023 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-004959 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0001346824-26-000216 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002045 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001406 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-29 | 8-K | 0001193125-26-326785 | View SEC Doc Filr Page |
| 424B5 | 2026-07-30 | — | 424B5 | 0001193125-26-326370 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | 8-K | 0001193125-26-323628 | View SEC Doc Filr Page |
| 424B5 | 2026-07-29 | — | 424B5 | 0001193125-26-323616 | View SEC Doc Filr Page |
| EFFECT | 2026-07-10 | — | EFFECT Filing | 9999999995-26-002261 | View SEC Doc Filr Page |
| S-3 | 2026-07-02 | — | S-3 | 0001193125-26-294457 | View SEC Doc Filr Page |
| S-8 | 2026-05-26 | — | S-8 | 0001193125-26-237305 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001181186-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001587788-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001771423-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001669080-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001278219-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001741836-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001273306-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001770390-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001936799-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001259780-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0001771498-26-000005 | View SEC Doc Filr Page |